KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Kye Young Lee

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 8건 중 1-8 번을 표시중입니다.

1 Article A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation-positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemorad Juwhan Choi ; Jeong Eun Lee ; Chang-Min Choi ; et al 2022
2 Article Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting 김호철 ; 최창민 ; Chan Kwon Park ; et al 2021
3 Article First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea Mi-Hyun Kim ; Chang Min Choi ; Sung Yong Lee ; et al 2022
4 Article Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial Margarita Majem ; Jonathan W Goldman ; Thomas John ; et al 2022
5 Article Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cance Su Yeon Lee ; Young Chul Kim ; Kye Young Lee ; et al 2022
6 Article Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC 김상위 ; Ajlan Atasoy ; Charuwan Akewanlop ; et al 2021
7 Article Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC Sang-We Kim ; Kye Young Lee ; Ajlan Atasoy ; et al 2022
8 Article Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea 최창민 ; Chan Kwon Park ; Cheol-Kyu Park ; et al 2021

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.